We describe here the purification and quantification of a water-soluble cyclic form of enterobacterial common antigen (ECA CYC ) from Escherichia coli K-12 as well as information regarding its subcellular location and the genetic loci involved in its assembly. Structural characterization of purified ECA CYC molecules obtained from E. coli K-12 revealed that they uniformly contained four trisaccharide repeat units, and they were substituted with from zero to four O-acetyl groups. Cells from overnight cultures contained approximately 2 g ECA CYC per milligram (dry weight), and cell fractionation studies revealed that these molecules were localized exclusively in the periplasm. The synthesis and assembly of ECA CYC were found to require the wzxE and wzyE genes of the wec gene cluster. These genes encode proteins involved in the transmembrane translocation of undecaprenylpyrophosphate-linked ECA trisaccharide repeat units and the polymerization of trisaccharide repeat units, respectively. Surprisingly, synthesis of ECA CYC was dependent on the wzzE gene, which is required for the modulation of the polysaccharide chain lengths of phosphoglyceride-linked ECA (ECA PG ). The presence of ECA CYC in extracts of several other gram-negative enteric organisms was also demonstrated; however, it was not detected in cell extracts of Pseudomonas aeruginosa. These data suggest that in addition to ECA PG , ECA CYC may be synthesized in many, if not all, members of the Enterobacteriaceae.
Enterobacterial common antigen (ECA) is a cell surface glycolipid that is present in all gram-negative enteric bacteria thus far examined (19, 23, 25, 38) . The carbohydrate portion of the polymer contains the amino sugars N-acetyl-D-glucosamine (GlcNAc), N-acetyl-D-mannosaminuronic acid (ManNAcA), and 4-acetamido-4,6-dideoxy-D-galactose (Fuc4NAc). These amino sugars are linked to one another to form linear polysaccharide chains that are comprised of the trisaccharide repeat unit3 3-␣-D-Fuc4NAc-(13 4)-␤-D-ManNAcA-(13 4)-␣-D-GlcNAc- (13 (22, 24) . In addition, the hydroxyl groups at position 6 of the GlcNAc residues are nonstoichiometrically substituted with O-acetyl groups (11, 22) . Individual ECA polysaccharide chains are covalently linked to diacylglycerophosphate via glycosidic linkage between the potential reducing terminal GlcNAc residue and the phosphate residue of the aglycone (19, 20, 36) . The polysaccharide chains of ECA obtained from Escherichia coli K-12 comprise a modal population of polymers ranging in chain length from 1 to 14 repeat units, with a modal value of 6 to 7 repeat units (2) . The phosphoglyceride portion serves to anchor the polymers in the outer leaflet of the outer membrane (1, 39) . Accordingly, phosphoglyceride-linked ECA is referred to as ECA PG , and it has been estimated that it accounts for approximately 0.2% of the cellular dry weight of E. coli K-12 (21, 24) .
The trisaccharide repeat unit of ECA PG is assembled as the lipid carrier-linked intermediate Fuc4NAc-ManNAcA-GlcNAc-pyrophosphorylundecaprenol (lipid III; Fuc4NAc-ManNAcA-GlcNAc-PP-Und) (3, 4, 37, 38) . The genes involved in the assembly of lipid III, as well many of the other genes involved in the utilization of lipid III for the assembly of ECA PG , are located in the wec gene cluster at approximately 85.4 min on the E. coli chromosome (2, 7, 24, 32) . Our current understanding of the pathway of ECA PG biosynthesis and the function of the genes that comprise the wec gene cluster have been recently described (12) . Steps of the assembly process that are pertinent to this communication are summarized in Fig. 1 .
In addition to containing ECA PG on the cell surface, cell extracts prepared from Shigella sonnei phase I (11, 22) , Yersinia pestis (43) , and Plesiomonas shigelloides contain water-soluble cyclic polysaccharides comprised of ECA trisaccharide repeat units (6, 42) . These polysaccharides have been designated cyclic ECA (ECA CYC ). ECA CYC polysaccharides lack the phosphoglyceride aglycone of ECA PG , and they are shorter and more uniform with respect to their degree of polymerization than are the polysaccharides of ECA PG . For example, ECA CYC from Shigella sonnei phase I contains four to six trisaccharide repeat units (11) . More-recent studies have also demonstrated the occurrence of ECA CYC in cell extracts of E. coli B and E. coli K-12 (12) .
Recent reports have suggested that the ECA PG of Salmonella enterica serovar Typhimurium functions as a virulence factor for oral infection in mice by contributing to the resistance of the organism to bile salts (33) . In contrast, nothing is known concerning the function of ECA CYC . Furthermore, although the trisaccharide repeat units of ECA PG and ECA CYC are assembled by a common biosynthetic pathway (12) , subsequent steps involved in the assembly ECA CYC remain to be established. We describe here the separation, purification, and quantification of ECA CYC molecules obtained from soluble extracts of E. coli K-12 using reverse-phase high-pressure liq-uid chromatography (HPLC). Examination of soluble fractions obtained from the cytoplasm and periplasm revealed that ECA CYC is a periplasmic component of E. coli K-12. Data are also presented that support the conclusion that the synthesis of ECA CYC requires functional wzxE, wzyE, and wzzE genes, which encode proteins involved in the transmembrane translocation of lipid III, the polymerization of ECA trisaccharide repeat units, and the regulation of ECA polysaccharide chain length, respectively. ECA CYC was also detected in extracts obtained from several other members of the Enterobacteriaceae, thus suggesting the possibility that ECA CYC is a component of all gram-negative enteric bacteria.
MATERIALS AND METHODS
Bacterial strains and growth conditions. The bacterial strains used in this study are listed in Table 1 . Cultures were grown at 37°C with vigorous aeration in either Luria-Bertani (LB) broth (29) , proteose peptone beef extract broth (40) , or M9 minimal medium (29) containing 0.2% glucose (M9-glucose medium) and other required nutrients. Tetracycline, ampicillin, kanamycin, gentamicin, and chloramphenicol were added to media when appropriate to give final concentrations of 10 g/ml, 50 g/ml, 15 g/ml, and 30 g/ml, respectively. Transductions were carried out using phage P1 vir as described by Silhavy et al. (41) .
Construction of plasmids. Plasmid pRL147 containing the wild-type wecA allele under the control of the pBAD promoter of plasmid pBAD18 was constructed as previously described (35) . Plasmid pRL163 containing the wild-type wecG gene under the control of the pBAD promoter was constructed as follows. The wild-type wecG allele was obtained by PCR amplification using genomic DNA obtained from strain AB1133 as the template. The polynucleotides 5Ј-CACCATGAATAACAACACCACGGC-3Ј and 5Ј-AAAGAGAGGAAAATC ATAGGTTGCC-3Ј were used as forward and reverse primers, respectively. The amplified sequence (758 bp) was cloned into the TA cloning site of the pBAD102/D-TOPO vector (Invitrogen) according to the manufacture's instructions.
Plasmid pRL164 containing the 5Ј-wzyE-wecG-3Ј genes on a single DNA fragment of 2.1 kb was obtained by PCR amplification of the wzyE-wecG sequence using the genomic DNA of strain AB1133 as the template and 5Ј-CAC CATGAAGTCTGCTGCAATTCAGTGGCCTG-3Ј and 5Ј-TCTAGAGTGACC ACTCCGTCGC-3Ј as forward and reverse primers, respectively. The amplified sequence was cloned into the TA cloning site of the pBAD102/D-TOPO (Invitrogen) according to the manufacturer's instructions, thus placing both genes under the control of the pBAD promoter.
Plasmid pRL165 containing the wild-type wzxE gene under the control of the lac promoter was obtained by PCR amplification of the genomic DNA of AB1133 using 5Ј-CTTTGTTGAATTCCTTTTCCTGA-3Ј and 5Ј-CCCAGTACGTGGATC CGTACAGTC-3Ј as forward and reverse primers, respectively. EcoRI and BamHI restriction sites were incorporated into the forward and reverse primers (underlined sequences), respectively. The amplified product (1,267 bp) was digested with EcoRI and BamHI, and the product was ligated into the corresponding sites of the plasmid vector, pBAD24 (15) , immediately downstream from the vectorencoded Shine-Dalgarno sequence located in the multicloning site of the vector. The cloned fragment, together with the 5Ј Shine-Dalgarno sequence, was obtained by PCR amplification with 5Ј-CTACTGTTTATCGATACCCG-3Ј and 5Ј-AGCCAAGCTTGCATGCCTGC-3Ј as forward and reverse primers, respectively (the ClaI restriction site is underlined). The PCR product was digested with ClaI and BamHI and ligated into the corresponding sites in the multicloning site of the expression plasmid pBluescript KSϩ immediately downstream from the lac promoter. A fragment containing the 5Ј-lac promoter-Shine-Dalgarno sequence-wzxE gene-3Ј was obtained by PCR amplification with 5Ј-GTGCTG CAAGGCGTTTAAATTG-3Ј and 5Ј-CGATTCTTTAAAGCAGCTGGCA-3Ј as forward and reverse primers, respectively. A DraI restriction site was incorporated into both primers (underlined). The PCR product was then digested with DraI, and the fragment was ligated into the corresponding site of the vector, pACYC184, to yield plasmid pRL165.
Plasmid pRL166 containing wild-type wzxC under the control of the lac promoter was obtained by PCR amplification using the genomic DNA of strain AB1133 as the template and 5Ј-GGTTTCGGTACCAAAGCGG-3Ј and 5Ј-CTTATCAGGCCTGCAGGTCC-3Ј as forward and reverse primers, respectively. KpnI and PstI restriction sites (underlined) were incorporated into the forward and reverse primers, respectively. The PCR product (1.6 kb) was digested with KpnI and PstI, and the resulting fragment was ligated into the corresponding sites located immediately downstream of the lac promoter in the multicloning site of the expression vector pBluescript KSϩ. A fragment including the lac promoter of the vector and the downstream wild-type wzxC gene was obtained from this construct by digestion with the restriction enzyme PvuII, and the fragment was ligated into the PvuII site of the vector pACYC184, to yield plasmid pRL166.
Plasmid pRL169 containing the wild-type wzx O16 gene under the control of the lac promoter was obtained by PCR amplification using the genomic DNA of strain AB1133 as the template and 5Ј-CTTATAAGCTTAGGAGGAATTGCA TGAATACG-3Ј and 5Ј-CATTCGCACAAACTGCAGCA-3Ј as forward and reverse primers, respectively. HindIII and PstI restriction sites were incorporated into the forward and reverse primers, respectively (underlined sequences). In addition, the forward primer also contained a Shine-Dalgarno sequence (bold sequence) located 6 base pairs upstream of the translational start codon (bold italic sequence). The product (1.3 kb) was digested with the restriction enzymes HindIII and PstI, and the resulting fragment was ligated into the corresponding sites located immediately downstream from the lac promoter in the multicloning site of the expression vector pBluescript KSϩ. A fragment (1.7 kb) including the wild-type wzx O16 gene and the upstream lac promoter of the vector was obtained from this construct by PCR amplification using 5Ј-GTGCTGCAAGGCGTT TAAATTG-3Ј and 5Ј-CGATTCTTTAAAGCAGCTGGCA-3Ј as forward and reverse primers, respectively. A DraI restriction site was incorporated into both of these primers (underlined). The product was digested with the restriction enzymes PvuII and SmaI, and the resulting 1.6-kb fragment containing the 5Ј-lac promoter-Shine-Dalgarno sequence-wzx O16 gene-3Ј was ligated into the DraI site of the vector pACYC184, to yield plasmid pRL169.
Mass spectrometry (MS) studies. Matrix-assisted laser desorption ionizationtime of flight (MALDI-TOF) mass spectra were obtained using an Applied Biosystems Voyager-DE STR biospectrometry workstation. Calibrations were conducted in the reflector mode using the peptide adrenocorticotropic hormone. Samples were analyzed using a laser intensity of 2,200. The matrix was 2,5-dihydroxybenzoic acid at a concentration of 10 mg/ml in 20% acetonitrile. Spectra were acquired in the negative mode.
Isolation of soluble periplasmic and cytoplasmic contents. The soluble periplasmic fraction of cells was released by osmotic shock using a modification of the procedure described by Rech et al. (34) . Briefly, cells were grown to Cloning vector 10 pRL147
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Wild-type wecG under the control of the pBAD promoter in pBAD102/D-TOPO stationary phase in LB broth at 37°C. The cells were harvested by centrifugation at 4°C and resuspended in osmotic shock buffer (0.5 M sucrose, 0.1 M Tris-HCl, pH 8.2, and 1 mM EDTA) at a ratio of 5 ml buffer to 1 g (wet weight) of cells. The cells were placed on ice for 10 min and then isolated by centrifugation at 4°C. The supernatant solution was discarded, and the cell pellet was resuspended in 5 mM MgSO 4 and incubated on ice for 10 min. The supernatant solution containing the soluble periplasmic contents was isolated by centrifugation at 12,000 ϫ g for 10 min at 4°C, and it was either analyzed immediately or stored at Ϫ20°C. The particulate fraction containing the osmotically shocked cells was resuspended in 5 mM MgSO 4 in an ice bath, and the soluble cytoplasmic fraction was released by sonication. Cellular debris was removed by centrifugation at 100,000 ϫ g for 1 h at 4°C, and the supernatant solution containing the soluble cytoplasmic contents was either analyzed immediately or stored at Ϫ20°C. This procedure resulted in the detection of ␤-galactosidase and ␤-lactamase activities only in the cytoplasmic and periplasmic fractions, respectively, when these fractions were obtained from strain PR4227 (W3110/pBR322) grown in the presence of 100 M isopropylthiogalactoside. The concentrations of protein in cell extracts, cytoplasmic fractions, and periplasmic fractions were determined using the Bio-Rad protein assay reagent according to the procedure recommended by the manufacturer. Identification and isolation of ECA CYC molecules. To identify ECA CYC molecules in cell extracts, cells were grown in 25 ml of M9-glucose medium at 37°C for 12 h and harvested by centrifugation (10,000 ϫ g, 4°C). The cells were washed with 5 mM MgSO 4 , resuspended in 10 ml of 5 mM MgSO 4 , and disrupted by sonication at 0°C. Cellular debris was removed by centrifugation (10,000 ϫ g, 4°C) followed by centrifugation of the supernatant solution at 100,000 ϫ g for 1 h at 4°C. Absolute ethanol (1.5 volumes) was added to the supernatant solution obtained from the high-speed centrifugation, and the mixture was incubated at 70°C for 5 min. The resulting precipitate was removed by centrifugation (10,000 ϫ g, 4°C), and the supernatant solution was reduced to dryness under vacuum at 0 to 4°C. The residue was resuspended in distilled deionized water (ddH 2 O; 1 ml), and particulate matter was removed by filtration using a Millex-GV filter unit (Millipore) containing a 4-mm Durapore polyvinylidene difluoride membrane (0.22-m pore size). Samples of the filtrate (100 l) were analyzed by reverse-phase high-pressure liquid chromatography using an Agilent 1100 series instrument and a Nucleosil C 18 column (4.6 by 250 mm, 5-m particle size, 300-Å pore size; Thermo Electron Corp.). Chromatographic analyses were carried out at room temperature with a linear gradient of 0 to 30% acetonitrile in an acidic phosphate solution (50 mM NaOH adjusted to pH 2.0 with 85% phosphoric acid and containing sodium azide at a final concentration of 0.0005%) at a flow rate of 0.5 ml/min. Carbohydrate-containing fractions were detected by their absorbance at 206 nm.
The ECA CYC molecules that eluted in peaks 1 to 5 ( Fig. 2A) were collected separately for analysis by MALDI-TOF. The material in these fractions was dried under vacuum and subsequently dissolved in 100 l of ddH 2 O. The samples were desalted by passage through a ZipTip C18 pipette tip (Millipore Corp.) using a modification of the procedure recommended by the manufacturer. Briefly, the C 18 bed in the pipette tips was wetted with 100% acetonitrile and then equilibrated with 0.1% trifluoroacetic acid (TFA) in ddH 2 O. The aqueous samples were adsorbed onto the C 18 bed and eluted with 5 l of 50% acetonitrile in ddH 2 O.
Purified ECA CYC molecules in peak 1 ( Fig. 2A ) were isolated on a preparative scale using reverse-phase HPLC. Strain PR4227 was grown with vigorous aeration in 1 liter of LB broth at 37°C for 12 h, and the cells were harvested by centrifugation (10,000 ϫ g, 4°C). Subsequent steps were the same as those described for the identification of ECA CYC in cell extracts, with the exception that the volume of the samples injected onto the Nucleosil C 18 column was 300 l, and the column was developed with a linear gradient of 0 to 15% acetonitrile in the previously described acidic (pH 2.0) phosphate solution. The material in peak 1 ( Fig. 2A) dissolved in 500 l ddH 2 O and desalted by reverse-phase HPLC as described above. Chromatography was carried out at room temperature at a flow rate of l ml/min using a linear gradient 0 to 100% acetonitrile in ddH 2 O. Following sample injection, the column was washed with ddH 2 O for 15 min and then developed with a linear gradient of acetonitrile over a period of 30 min. Column fractions were monitored at 206 nm, and a single component was detected. The fractions containing this component were collected and then dried under vacuum. The dried material from three such preparations was dissolved in 500 l ddH 2 O and stored at Ϫ20°C. Treatment of ECA CYC with alkali. Strain PR4227 was grown in 25 ml of M9-glucose medium at 37°C for 12 h and harvested by centrifugation (10,000 ϫ g, 4°C). The cells were washed with 5 mM MgSO 4 , resuspended in 10 ml of MgSO 4 , and then disrupted by sonication at 0°C. Cellular debris was removed by centrifugation (10,000 ϫ g, 4°C), followed by centrifugation of the supernatant solution at 100,000 ϫ g for 1 h at 4°C. Absolute ethanol (1.5 volumes) was added to the supernatant solution, and the mixture was incubated at 70°C for 5 min. The resulting precipitate was removed by centrifugation (10,000 ϫ g, 4°C), and the supernatant solution was reduced to dryness under vacuum at 0 to 4°C. The residue was dissolved in ddH 2 O (500 l), to which was then added 40 l of 4 N NaOH. The mixture was incubated for 15 min at 37°C and then acidified by the addition of 200 l of 4 N HCl. The acidified reaction mixture was next filtered using a Millex-GV filter unit (Millipore) containing a 4-mm Durapore polyvinylidene difluoride membrane (0.22-m pore size). Aliquots of the filtered reaction mixture were then analyzed by reverse-phase HPLC using the methods described above for the identification of ECA CYC in whole-cell extracts.
Quantification of ECA CYC . The amount of ECA CYC in extracts was determined by establishing the relationship between a given chemical quantity of ECA CYC and the corresponding area of the peak generated by its absorbance at 206 nm when analyzed by reverse-phase HPLC. ECA CYC (peak 1) ( Fig. 2A ) was purified on a preparative scale as described above. The chemical quantity of the ECA CYC in these preparations was determined by quantifying the amount of glucosamine released from aliquots of these preparations following total acid hydrolysis. Samples containing various amounts of ECA CYC in a total volume of 10 l were mixed with an equal volume of 8 M TFA and incubated for 7 h at 100°C in a sealed tube. The hydrolysate was then dried under vacuum, washed with isopropanol (40 l), and then dried under vacuum. The free glucosamine in hydrolysates was analyzed by HPLC as the corresponding p-aminobenzoic acid ethyl ester (ABEE) monosaccharide derivative using an ABEE labeling kit (Honen Corp., Tokyo, Japan) according to the manufacturer's instructions. Briefly, samples were dissolved in ddH 2 O (10 l), to which was added ABEE labeling reagent (40 l). The reaction mixtures were incubated for 1 h at 80°C and then cooled to room temperature. Chloroform (200 l) and ddH 2 O (200 l) were added to reaction mixtures with mixing, the upper aqueous layer was removed, and aliquots were analyzed for the ABEE-glucosamine derivative by reverse-phase HPLC using a Nucleosil C 18 column (250 by 4.7 mm, 300-Å pore size; Thermo Electron Corp.) and a linear gradient of 10% to 50% acetonitrile in 0.02% TFA at a flow rate of 1 ml/min at 45°C. The ABEE derivative of glucosamine was detected by fluorescence monitoring (excitation at 305 nm and emission at 360 nm). A standard curve was constructed with known amounts of N-acetyl-D-glucosamine that were then subjected to total acid hydrolysis and converted to the ABEE derivative using the procedures described above. This assay was linear over the entire range of GlcNAc concentrations examined (0.08 to 1.28 nmol). The amount of ECA CYC in samples was calculated based on the observation that single ECA CYC molecules in E. coli K-12 uniformly contain four trisaccharide repeat units (12) and that each repeat unit contains one GlcNAc residue. Accordingly, a standard curve was constructed relating known amounts of ECA CYC to the areas of their corresponding peaks generated by their absorbance at 206 nm when analyzed by reverse-phase HPLC. This assay was linear over the entire range of ECA CYC concentrations examined (110 to 710 pmol).
Passive hemagglutination. The presence of ECA in cell extracts was determined by passive hemagglutination assay with monospecific polyclonal rabbit anti-ECA as previously described (37) .
RESULTS
Characterization of ECA CYC molecules in cell extracts. Erbel et al. (12) reported the occurrence of water-soluble ECA CYC molecules in cell extracts of E. coli B and E. coli K-12. These cyclic polysaccharides were found to contain four ECA trisaccharide repeat units. Earlier studies established that position 6 of GlcNAc residues in linear ECA PG polymers are nonstoichiometrically substituted with O-acetyl groups (11, 22) . Analyses of the ECA CYC preparations by mass spectrometry indicated that they also contained O-acetyl groups, and five molecular species were identified owing to the nonstoichiometric substitution of molecules with up to four O-acetyl residues (12). However, the mass spectrometry data obtained in these studies were obtained from unfractionated ECA CYC preparations. The separation of individual molecular species of ECA CYC has not been reported. Thus, we employed reversedphase high-performance liquid chromatography and MALDI-TOF MS) to separate and identify the five ECA CYC molecular species in extracts of E. coli K-12.
As shown in Fig. 2A , five prominent molecular species were detected when extracts of E. coli strain PR4227 (wild type, W3110/pBR322) were analyzed by reverse-phase HPLC. Under the conditions employed, these species eluted at 79 min (peak 1), 99 min (peak 2), 119 min (peak 3), 143 min (peak 4), and 160 min (peak 5) in a ratio of approximately 1.0:2.1:4.6: 3.5:1.8, respectively. The molecules in these peaks were tentatively identified as ECA CYC molecules since they were water soluble and they were not detected in extracts of strain PR4228, a derivative of strain PR4227 that is unable to synthesize ECA CYC due to a null mutation in the wecA gene (Fig. 2B) . The relative amounts of the individual species were very similar to those reported by Erbel et al. (12) . MALDI-TOF MS analyses of the molecules in peaks 1, 2, 3, 4, and 5 revealed molecular
ions ([MOH]
Ϫ ) that were in agreement with those predicted to be derived from ECA CYC parent molecules containing four trisaccharide repeat units substituted with zero, one, two, three, and four O-acetyl groups ( Table 2 ). The calculated mass of a linear ECA polysaccharide containing Further support for the conclusion that ECA CYC molecules in peaks 2, 3, 4, and 5 are O acetylated was provided by treatment of the ECA CYC preparation described above with mild alkali. This treatment resulted in the loss of these peaks and was accompanied by a pronounced increase in the amount of ECA CYC molecules devoid of O-acetyl groups in peak 1 (Fig. 2C) .
Subcellular localization and the cellular content of ECA CYC molecules. Previous estimates of the amount of ECA CYC in cells of E. coli B using indirect methods indicated that cells grown overnight in broth contain approximately 2 g ECA CYC per milligram of dried cells (12) . Assuming that ECA CYC molecules have an average molecular mass of 2,513 Da, this amount corresponds to approximately 795 pmol of ECA CYC per milligram (dry weight) of cells. The ECA CYC content in cell extracts prepared from E. coli K-12 cells (strain PR4227) that were grown overnight in broth was determined by direct measurement of the amount of de-O-acetylated ECA CYC present in extracts following treatment with mild alkali. These results were in excellent agreement with the data obtained from earlier estimates; cell extracts contained approximately 2 g of ECA CYC per milligram (dry weight) of cells (Table 3) . Examination of subcellular fractions revealed that approximately 80% of the ECA CYC was released from the cells by osmotic shock, and essentially no ECA CYC was found in the cytoplasm. The inability to quantitatively recover ECA CYC in the soluble material released by osmotic shock is most likely due to losses incurred during the preparation of this fraction. In addition, no ECA CYC was detected in cell-free culture filtrates (data not shown). These observations support the conclusion that ECA CYC resides exclusively in the periplasm.
The synthesis of ECA CYC was not restricted to exponentially growing cells. Significant synthesis occurred in cells in the late exponential phase of growth and continued for a prolonged period after the cells had entered stationary phase (Fig. 3) . Similar results were obtained with cells grown in M9-glucose minimal medium and proteose peptone beef extract broth (data not shown).
The assembly of ECA CYC requires the wzyE gene. Lipid III is a precursor for the synthesis of both ECA CYC and the linear polysaccharide chains of ECA PG (12) . The available evidence supports the conclusion that lipid III is synthesized on the inner face of the cytoplasmic membrane and subsequently translocated en bloc across the membrane to the periplasmic face, where it is utilized for the assembly of the linear polysaccharide chains of ECA PG . Recent experiments have provided support for the conclusion that the transbilayer movement of lipid III across the cytoplasmic membrane is mediated by a translocase or "flippase" encoded by the wzxE gene (35) . Subsequent assembly of ECA polysaccharide chains occurs by the "block polymerization" mechanism described for the assembly of wzy-dependent O-antigen polysaccharides (17) , and this reaction is catalyzed by a polymerase encoded by the wzyE gene.
The specific steps involved in the utilization of lipid III for the assembly of ECA CYC molecules remain to be established. Thus, initial experiments were conducted to determine if the synthesis of ECA CYC was dependent on the polymerase WzyE. Previous attempts to address this question have been hampered by the loss of cell viability that accompanies the insertional inactivation of wzyE; this phenotype is believed to be due to the accumulation of lipid III in the cytoplasmic membrane (unpublished results). However, an experimental approach to this problem was made possible by the construction of strains that possessed null mutations in both wecG and wzyE but that were unaltered in cell growth when they were grown under specific conditions. Null mutations in wecG preclude the synthesis of ECA CYC and ECA PG due to the inability of these mutants to synthesize lipid III (Fig. 1) . However, experiments with strain PR4214 (wecG::Tn10/pRL163 [with wild-type wecG under the control of the P BAD promoter]) revealed that the "leaky" or basal-level expression of wild-type wecG from the P BAD promoter in the absence of exogenously supplied arabinose is sufficient to rescue the ability of this strain to synthesize both ECA CYC and ECA PG (Table 4) . Normal growth accompanied the basal level expression of wild-type wecG from the P BAD promoter in strain PR4216, a derivative of strain PR4214 that also possesses a null mutation in wzyE; however, FIG. 3 . Synthesis and accumulation of ECA CYC in strain PR4227 (wild type, W3110/pBR322) as a function of growth stage. ■, absorbance at 600 nm; E, nanomoles of ECA CYC per 100 ml of culture. Additional details are provided in "Materials and Methods." synthesis of both ECA CYC and ECA PG were abolished. Presumably, the basal level of wecG expression results in the synthesis of sufficient amounts of lipid III to support the synthesis of ECA CYC and ECA PG in strains that possess a wildtype wzyE allele. However, this level of wecG expression does not appear to result in the accumulation of deleterious amounts of lipid III in mutants lacking a functional wzyE gene product. Experiments using strain PR4217 (wecG::Tn10 wzyE::gm/pRL164) revealed that the inability to synthesize ECA CYC and ECA PG was complemented by the basal-level expression of the wild-type wzyE and wecG alleles from a common P BAD promoter on plasmid pRL164. The amount of ECA CYC synthesized by strain PR4217 was approximately fourfold greater than that observed in strain PR4214, and this most likely reflects a gene dosage-related increase in WzyE activity due to the elevated copy number of the pBAD102/D-TOPO vector. These data support the conclusion that a functional polymerase (WzyE) is required for the assembly of ECA CYC .
The assembly of ECA CYC requires the wzzE gene. WzyEmediated polymerization of the linear chains of ECA PG occurs by a mechanism that involves the modulation of polysaccharide chain length to yield a modal population of polymers, and this modulation is mediated by the wzzE gene product (2) . Null mutations in wzzE do not block the synthesis of ECA PG molecules, but they result in the synthesis of ECA PG molecules having a random nonmodal distribution of polysaccharide chain lengths (2) . In contrast to the synthesis of ECA PG , the synthesis of ECA CYC was abolished in strains PR4219 and PR4220, both of which possess an insertion of a nonpolar cassette carrying the aphA-3 kanamycin resistance determinant of Enterococcus faecalis (28) in the wzzE gene ( Table 4) . As shown for strain PR4221 (wzzE::km/pCA53) (Table 3) , the defect in ECA CYC synthesis due to the null mutation in wzzE was rescued by expression of the wild-type wzzE allele in plasmid pCA53. These results indicate that wzyE-mediated polymerization of ECA trisaccharide repeat units must be accompanied by wzzE-mediated chain length regulation as a prerequisite for the assembly of ECA CYC molecules.
The assembly of ECA CYC requires the wzxE gene. The dependence of ECA CYC assembly on functional wzyE and wzzE gene products supports the conclusion that the assembly of ECA CYC molecules from lipid III occurs on the periplasmic face of the cytoplasmic membrane. Therefore, this assembly process should be dependent on the transbilayer movement of lipid III. Accordingly, attempts were made to examine the role of wzxE in the assembly of ECA CYC . Previous such attempts have been severely hampered by the lethal phenotype of wzxE null mutants. Thus, the arabinose-induced expression of wildtype wecA in E. coli PR4180 [⌬(wzx O16 wzxC) wecA::Tn10 wzxE::cm/pRL147, wild-type wecA under the control of the P BAD promoter] resulted in a pronounced loss of cell viability, and this was accompanied by the accumulation of lipid III (35) . However, normal cell growth, synthesis of ECA PG , and synthesis of wild-type levels of ECA CYC occurred following expression of both the wild-type wecA and wzxE genes under the control of the P BAD and lac promoters, respectively, in a similar strain, strain PR4210 [⌬(wzx O16 wzxC) wecA::Tn10 wzxE::km/pRL147 pRL165 (Table 4) ]. This observation is in agreement with the conclusion that WzxE functions as a translocase for the transbilayer movement of lipid III across the cytoplasmic membrane, where it is subsequently utilized for the synthesis of ECA CYC . It was somewhat surprising to observe that null mutations in wzxE did not affect the cell viability or the synthesis of ECA PG and ECA CYC in strain PR4223 (wecG::Tn10 wzxE::cm/wild-type wecG under the control of the P BAD promoter) following the expression of wecG (Table 4) . However, unlike strain PR4180, which was derived from parental strain S874 [⌬(wzx O16 wzxC)] (Table 1) , strain PR4223 was derived from parental strain W3110, which possesses wild-type wzx O16 and wzxC genes; these genes encode the putative translocases involved in the assembly of the O16 O antigen and colanic acid, respectively. These observations suggested the possibility that either Wzx O16 or WzxC or perhaps both of these putative translocases are able to mediate the transbilayer movement of lipid III in the absence of functional WzxE. Indeed, as shown by the data obtained with strain PR4236, expression of the wild-type wzxC gene was able to complement the defects in cell viability, synthesis of ECA PG , and synthesis of ECA CYC due to the null mutation in wzxE (Table 4) . In addition, similar data were obtained with strain PR4233 as a result of the expression of the wild-type wzx O16 gene in the same genetic background. In both cases, the synthesis of ECA CYC was not fully restored to wild-type levels; however, these data nevertheless suggest that both WzxC and Wzx O16 are able to mediate the translocation of lipid III across the cytoplasmic membrane.
Occurrence of ECA CYC in other gram-negative enteric organisms. The lack of a convenient method for the detection of ECA CYC is largely responsible for the fact that ECA CYC has been demonstrated only in the cell extracts of a few gramnegative organisms (6, 11, 22, 42, 43) . Accordingly, the possibility that it is present in all members of the Enterobacteriaceae has remained open. The recent demonstration of ECA CYC in cell extracts of E. coli B and E. coli K-12 (12) suggested the possibility of its occurrence among other members of the Enterobacteriaceae. A limited survey of other gram-negative enteric bacteria using the assay described here revealed the occurrence of ECA CYC in all of the organisms examined (Table 5 ). However, ECA CYC was not detected in the nonenteric gram-negative organism Pseudomonas aeruginosa.
DISCUSSION
ECA CYC has been reported to occur in only a few gramnegative enteric organisms owing to the lack of a convenient assay for its detection. The limited survey described here revealed the presence of ECA CYC in all gram-negative enteric bacteria examined. In addition, inspection of complete bacterial genome sequences contained in the National Center for Biotechnology Information database revealed that the wec gene cluster is present in all members of the Enterobacteriaceae; however, it is not present in other Gammaproteobacteria. Thus, there exists the potential for synthesis of ECA CYC in many, if not all, gram-negative enteric bacteria, and it appears likely that it is unique to these organisms.
It is interesting to note that the degree of polymerization of ECA CYC molecules obtained from various gram-negative enteric organisms does not appear to be uniform. Thus, ECA CYC molecules obtained from Shigella sonnei phase I have been reported to contain four to six trisaccharide repeat units (11) , whereas those of E. coli B and E. coli K-12 uniformly contain four repeat units (12; this study). However, the basis for this variation is not understood.
It has been previously established that the GlcNAc residues in the linear polysaccharide chains of ECA PG are nonstoichiometrically O acetylated at position 6 (11, 22) . Structural analyses of ECA CYC molecules obtained from E. coli B and E. coli K-12 revealed that they are also O acetylated to various degrees (12) . Accordingly, when these organisms were grown in broth cultures, they synthesized ECA CYC molecules that are substituted with from zero to four O-acetyl groups. Although the location of these O-acetyl groups has not been determined, it seems probable that they are also located at position 6 of GlcNAc residues. In this regard, both the degree to which the ECA CYC molecules of E. coli K-12 are O acetylated and the total amount of ECA CYC synthesized by cells appear to be highly dependent on the composition of the culture medium in which the cells are grown. The synthesis of molecules containing one to four O-acetyl groups occurs to a much greater degree when cells are grown in M9-glucose minimal medium than when cells are grown in rich broth (unpublished results). In contrast, the synthesis of all ECA CYC species is significantly reduced when cells are grown in MOPS (morpholinepropanesulfonic acid)-glucose minimal medium (13) . The basis for the relationship between ECA CYC synthesis and the composition of the growth medium remains to be established.
Previous studies established that lipid III is used for the synthesis of both ECA PG and ECA CYC (12) . The assembly of ECA PG involves translocation of lipid III across the cytoplasmic membrane by the flippase WzxE and its subsequent utilization as a substrate for WzyE-mediated "block polymerization" of trisaccharide repeat units (Fig. 1) . In addition, the polymerization process is accompanied by the modulation of polysaccharide chain lengths by WzzE to yield a modal population of linear polymers comprised of approximately 1 to 14 repeat units with an apparent modal value of 5 to 7 (2). The linear polysaccharide chains are then transferred from the lipid carrier to an as-yet-unidentified diacylgycerol-containing ac- ceptor to yield ECA PG ; however, the mechanism of this reaction remains to be established. Data obtained in the current study demonstrate that ECA CYC is also assembled by a mechanism that requires WzxE-and WzyE-mediated transmembrane translocation and polymerization, respectively. Figure 4 depicts a proposed model for the assembly of ECA CYC that is based on the currently available data. Accordingly, following the WzxE-mediated translocation of lipid III across the cytoplasmic membrane, subsequent reactions involve the WzyEmediated polymerization of trisaccharide repeat units and cyclization. Nothing is known concerning the mechanism of the cyclization reaction or the enzyme that catalyzes this reaction. It is possible that cyclization involves the formation of an O-glycosidic linkage as a result of the transfer of the potential reducing terminal GlcNAc residue from an undecaprenylpyrophosphate-linked linear polysaccharide chain to the nonreducing terminal Fuc4NAc residue of the same chain. As previously stated, the ECA CYC molecules synthesized by E. coli B and E. coli K-12 uniformly contain four trisaccharide repeat units (12) . Thus, in the case of the mechanism proposed above, close coordination between the cyclization and polymerization reactions would be necessary in order to maintain stringent control of the degree of polymerization. Although this model predicts that lipid III is a precursor of ECA CYC , a direct precursorproduct relationship has not yet been demonstrated.
Quite surprisingly, our studies revealed that synthesis of ECA CYC is dependent on WzzE, the modulator of ECA polysaccharide chain length. Although two models have been proposed for how Wzz proteins function to regulate the chain length of lipopolysaccharide O antigens (5, 30), essentially nothing is known concerning the mechanism of this process. Similarly, the mechanism involved in the WzzE-mediated modulation of the chain lengths of ECA PG polysaccharides remains to be established. Null mutations in wzzE result in a random nonmodal distribution of ECA PG polysaccharide chains in which the amount of polymer of a given chain length appears to be inversely related to chain length (2). Thus, although ECA PG molecules containing polysaccharides comprised of four repeat units are relatively more abundant than ECA PG molecules with polysaccharides having greater degrees of polymerization, the abundance of ECA PG molecules, regardless of their polysaccharide chain length, appears to be dramatically reduced in wzzE null mutants. Accordingly, it is possible that the cyclization reaction involved in ECA CYC synthesis is essentially abolished in wzzE null mutants as a result of a decreased availability of undecaprenylpyrophosphate-linked polysaccharide substrate. Alternatively, the activity of the enzyme responsible for the cyclization reaction may be dependent on the formation of a complex between WzyE and WzzE. Indeed, this complex may also include WzxE. As previously stated, neither the enzyme that catalyzes the cyclization reaction nor its structural gene has been identified. The available data do not exclude the possibility that either WzyE or WzzE is bifunctional and is able to catalyze the cyclization reaction as well as polymerization or modulation of polysaccharide chain length, respectively.
Previous studies determined that the flippases involved in the assembly of Wzy-dependent O antigens appear to have relaxed specificities for the structure of the oligosaccharide moiety of their substrates (14) . This conclusion is supported by FIG. 4 . Proposed model for the assembly of ECA CYC in Escherichia coli K-12. It is proposed that WzxE mediates the translocation of lipid III to the periplasmic face of the cytoplasmic membrane. The transmembrane translocation of lipid III is followed by the WzyE catalyzed "block polymerization" of ECA trisaccharide repeat units and cyclization to yield ECA CYC molecules containing four repeat units. The assembly of ECA CYC from lipid III also appears to be dependent on a functional polysaccharide chain length regulator (WzzE); however, the role of WzzE in the assembly process has not been established. The cyclization reaction presumably involves synthesis of an intramolecular glycosidic linkage between the potential reducing terminal GlcNAc residue of Fuc4NAc-ManNAcA-GlcNAc-(Fuc4NAc-ManNAcA-GlcNAc) 2 -Fuc4NAc-ManNAcA-GlcNAc-P-P-Und and the hydroxyl group in position 3 of the nonreducing terminal Fuc4NAc residue, thus resulting in the release of undecaprenylpyrophosphate. Neither the putative enzyme that catalyzes this reaction nor its structural gene has been identified. It is possible that the cyclization reaction is dependent on the formation of a complex between the putative "cyclase," WzyE and WzzE. Indeed, this complex may also include WzxE. Alternatively, it is possible that WzyE or WzzE is bifunctional and is able to catalyze the cyclization reaction as well as polymerization or chain length regulation, respectively. In either case, the assembly of ECA CYC from lipid III may be dependent on the formation of a membrane-bound complex that includes some or all of these proteins.
the data presented in this study that demonstrate that the WzxC and Wzx O16 translocators involved in the assembly of colanic acid and the O16 O antigen of E. coli, respectively, also appear able to translocate lipid III across the cytoplasmic membrane in vivo. However, the extent to which these translocators function in vivo for lipid III transbilayer movement is not clear. In contrast, the available data suggest that the substrate specificity of WzxE is rather stringent. Thus, WzxE appears to function only in vivo for the translocation of lipid III.
The dependence of ECA CYC synthesis on WzxE, WzyE, and WzzE clearly support the conclusion that this polymer is assembled in the periplasm. The data presented here also support the conclusion that ECA CYC resides in the periplasm; it was not detected in either in the cytoplasm or in culture filtrates. It is not known at what stage in the assembly of ECA CYC that the O acetylation of GlcNAc residues occurs. It seems likely that acetyl-coenzyme A is the donor of acetyl substituents, and it is possible that these groups are transferred to lipid III molecules prior to their WzxE-mediated translocation across the cytoplasmic membrane. Alternatively, O acetylation of nascent or completed ECA CYC molecules on the periplasmic side of the membrane might occur in a manner similar to that proposed for the transfer of succinyl residues by MdoC (8) . In either case, the enzyme responsible for catalyzing O acetylation remains to be identified.
It has recently been reported that the resistance of Salmonella enterica serovar Typhimurium to bile salts is dependent on the ability of cells to synthesize ECA (33) . However, it was not determined if this resistance was related to the occurrence of ECA PG or ECA CYC or to the presence of both forms of ECA. Data obtained in the present study revealed that the synthesis of ECA CYC is abolished in null mutants that lack the chain length regulator WzzE. In contrast, the synthesis of ECA PG is not abolished in these mutants, but its assembly in these mutants occurs without chain length modulation (2) . These mutants possess wild-type levels of resistance to bile salts (unpublished results). Therefore, it seems likely that the resistance of gram-negative enteric bacteria to bile salts is unrelated to the occurrence of ECA CYC in the periplasm, but it appears to be due to the presence of ECA PG in the outer membrane.
The function of ECA CYC in gram-negative enteric bacteria is not known. In some respects ECA CYC appears to be similar to the osmoregulated periplasmic glucans (OPGs) synthesized by many gram-negative Proteobacteria (8) . Although there are considerable differences in the structures of the OPGs synthesized by various species of Proteobacteria, all OPGs have the following characteristics: (i) glucose is the only carbohydrate component, (ii) all are oligosaccharides containing from 5 to 24 glucose residues that are primarily linked through ␤-glycosidic linkages, and (iii) they are localized exclusively in the periplasm. In addition, the OPGs of many Proteobacteria are cyclic glucans; however, several species synthesize linear glucans. Perhaps the best known of the linear OPGs are the membrane-derived oligosaccharides that were first discovered in E. coli (18) . A general characteristic of the OPGs synthesized by the vast majority of Proteobacteria, regardless of their structure, is that their concentrations within the periplasm increase in response to decreases in the osmolarity of the environment (8) . In this regard, the cyclic 1,2-␤-glucan synthesized by Brucella abortis appears to be an exception (16) . The function of OPGs has not been clearly defined, and mutants unable to synthesize OPGs display widely varied phenotypes (8) . Nevertheless, the periplasmic location and cyclic structures of ECA CYC and many OPGs make it tempting to speculate that they have similar functions. However, this appears unlikely since the composition and other structural features of ECA CYC and cyclic OPGs differ markedly, and the concentration of ECA CYC within the periplasm is considerably less than is the case for MDO and other OPGs. Assuming that E. coli cells growing in a medium of low osmolarity have a periplasmic volume of 0.31 l per milligram (dry weight) (9), the concentration of ECA CYC in the periplasm is about 2.5 mM. In contrast, the periplasmic concentration of membrane-derived oligosaccharides in cells grown in medium of low osmolarity is about 50 mM (18) . Furthermore, the concentration of ECA CYC within the periplasm does not appear to be affected by the osmolarity of the environment (unpublished results). Finally, the available data suggest that ECA PG and ECA CYC are synthesized only in gram-negative enteric bacteria. Therefore, unlike OPGs, which are found in a wide variety of gramnegative bacteria, it appears that ECA CYC serves an as-yetunknown function that is unique to members of the Enterobacteriaceae.
